News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Ethan James

Advertisement

Articles by Ethan James

Can AI explain AMD to patients?

ByEthan James,Geeta Lalwani, MD,Laxmi Devisetty, MD
August 14th 2025

Patients weigh in on the value of provider communication.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Modern Retina

    1

    FDA grants RMAT designation to RTx-015 optogenetic gene therapy for retinitis pigmentosa

    2

    Directional OCT provides biomarkers of Parkinson’s Disease in the outer retina

    3

    Merck launches phase 2b/3 MALBEC trial of MK-8748 in wet AMD

    4

    OLN324 shows comparable vision gains, potential durability advantage vs faricimab in phase 1b wAMD, DME study

    5

    FDA approves extended dosing intervals up to 20 weeks for EYLEA HD in wAMD and DME

    • About
    • Advertise
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    Brand Logo

    © 2026 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us